Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Does treatment with DMARDs decrease the risk of cardiovascular disease in patients with RA?

Nature Clinical Practice Rheumatology volume 3, pages 254–255 (2007)Cite this article

boxed-textvan Halm VP et al. (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case–control study. Arthritis Res Ther 8: R151

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Hall FC and Dalbeth N (2005) Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology 44: 1473–1482

    CAS  Article  Google Scholar 

  2. Choi HK et al. (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359: 1173–1177

    CAS  Article  Google Scholar 

  3. Krishnan E et al. (2004) Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 110: 1774–1779

    Article  Google Scholar 

  4. Solomon DH et al. (2006) Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 54: 3790–3798

    CAS  Article  Google Scholar 

  5. McCarey DW et al. (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363: 2015–2021

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Medicine, School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK fch22@medschl.cam.ac.uk

Affiliations

  1. FC Hall is ARC Rheumatology Lecturer and Honorary Consultant Rheumatologist in the Department of Clinical Medicine, University of Cambridge School of Medicine in Cambridge, UK.

    Frances C Hall

Authors
  1. Frances C Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

FC Hall has received an unrestricted grant for the development of a website from Pfizer.

FC Hall has received an unrestricted grant for the investigation of endothelial-derived microparticles in systemic sclerosis from Actelion.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hall, F. Does treatment with DMARDs decrease the risk of cardiovascular disease in patients with RA?. Nat Rev Rheumatol 3, 254–255 (2007). https://doi.org/10.1038/ncprheum0477

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0477

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing